Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation

New England Journal of Medicine

Volumn 344, Issue 14, 2001, Pages 1043-1051

  Ozcan, Cevher ^a   Jahangir, Arshad ^a   Friedman, Paul A ^a   Patel, Philip J ^a   Munger, Thomas M ^a   Rea, Robert F ^a   Lloyd, Margaret A ^a   Packer, Douglas L ^a   Hodge, David O ^a   Gersh, Bernard J ^a   Hammill, Stephen C ^a   Shen, Andwin Kuang ^a   Hayes, David L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR RISK; CATHETER ABLATION; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CASE-CONTROL STUDIES; CATHETER ABLATION; CAUSE OF DEATH; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACEMAKER, ARTIFICIAL; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0035810143     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200104053441403     Document Type: Article

References (33)

1. Impact of atrial fibrillation on the risk of death: The Framingham heart study
2. Atrial fibrillation and mortality in an elderly population
3. Epidemiologic features of chronic atrial fibrillation: The Framingham study
4. Mortality in an insured population with atrial fibrillation
5. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota
6. Atrial fibrillation as an independent risk factor for stroke: The Framingham study
7. Pharmacotherapy of atrial fibrillation
8. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: A staged care approach with new antiarrhythmic drugs
9. Management of atrial fibrillation
10. Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: Results of a comparative study and a 2-year follow-up
11. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter
12. Management of patients with atrial fibrillation: A statement for healthcare professionals
13. Atrioventricular nodal ablation and pacemaker implantation in patients with atrial fibrillation
14. Control of rapid heart rate in patients with atrial fibrillation: Drugs or ablation?
15. Ablate and pace: A pragmatic approach to paroxysmal atrial fibrillation not controlled by antiarrhythmic drugs
16. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias
17. Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: Effective treatment for drug refractory paroxysmal atrial fibrillation
18. The ablate and pace trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation
19. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: Impact of treatment in paroxysmal and established atrial fibrillation
20. Expected survival based on hazard rates
21. Catheter ablation of the atrioventricular junction using radiofrequency energy and a bilateral cardiac approach
22. Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction
23. Asymptotically efficient rank invariant test procedures
24. Regression models and life-tables
25. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study
26. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials: Studies of left ventricular dysfunction
27. Impact of atrial fibrillation on mortality, stroke, and medical costs
28. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: A randomized, controlled study
29. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: A randomized controlled study
30. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham study
31. The natural history of lone atrial fibrillation: A population-based study over three decades
32. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias